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 Increasing numbers of cancer patients seek complementary and integrative medicine 
approaches.1,2 Despite the considerable growth of integrative medicine offered in academic cancer 
centers,3 patient demand frequently outpaces availability. The Osher Center for Integrative Medicine at 
the University of California San Francisco (UCSF), for instance, previously closed its integrative oncology 
(IO) practice to new patients due to a >6 month wait-time.  
To achieve quality integrative cancer care, we must identify barriers to access and test models 
to address these barriers. A growing body of literature examines the safety, effectiveness, and patient 
centeredness of IO care. Some of our recent efforts focus on addressing the other three domains of 
healthcare quality defined by the Institute of Medicine (IOM): timely, efficient, and equitable care.4 
 Timely care reduces delays. Due to lengthy wait-times for appointments, cancer patients are 
often unable to see an integrative oncologist during active treatment, arguably the most critical time to 
receive integrative care. Barriers to timely care include longer visits and the limited numbers of trained 
providers. IO visits are frequently 60-120 minutes, which results in fewer patients being seen within a 
typical clinic. Though this visit length is important to the practice of IO– facilitating comprehensive, 
coordinated, and holistic care—it reduces availability.  
Efficient care improves coordination, which is a challenge at large cancer centers with multiple 
campuses and separate specialty clinics. Equitable care includes providing quality care irrespective of 
geographic location, socioeconomic status, or other individual and social factors. Barriers to equitable 
care include challenges posed by traditional in-person visits for patients who live far away. For example, 
80% of UCSF cancer patients live outside of San Francisco and commute an average of 67 miles through 
Bay Area traffic for their medical appointments.   
 In order to overcome these barriers (Table 1), we are exploring new models of care. We are 
piloting IO group visits, where 8-10 cancer patients and caregivers meet with an integrative oncologist 
for a series of visits on specific IO topics (e.g., nutrition, supplements, and mind-body medicine). We are 
also studying interventions that provide patient education on self-care utilizing digital health technology. 
Aspects of IO (e.g., some mind-body interventions) lend themselves well to this scalable format. 
Embedding integrative practitioners in oncology clinics, infusion centers, or inpatient settings, is another 
model that improves efficiency, as patients being seen for their usual oncologic care can simultaneously 
receive elements of IO care. Embedding also can allow for more coordinated and truly integrated care. 
Support between visits by health coaches and the use of telemedicine can motivate patients to adhere 
to diet and lifestyle regimens and help to optimize in-person time with providers.  
Triaging patients into the appropriate model of care is important for delivering effective and 
quality IO care. In some healthcare systems, an integrative oncologist may be expected to serve as a 
gatekeeper to complimentary or integrative modalities. Given the limited number of integrative 
oncologists, it’s important to consider ways to more judiciously and selectively (rather than routinely) 
use the integrative oncologist in this role. Clinical protocols and institutional guidelines can guide the 
use of complementary modalities for routine situations, such as for uncomplicated post-treatment 
survivorship care. A trained and experienced acupuncturist, for example, could provide integrative 
oncology care for select patients. While an integrative oncologist may be better utilized in medically 
complex situations, such as for a patient receiving a complex chemotherapy regimen. In addition to 
potentially allowing the more efficient use of resources, another advantage is that this approach 
emphasizes inter-professional care. However, out-of-pocket costs to patients have to be considered. 
 Patient-centered, safe, and effective IO care should be a part of comprehensive cancer care that 
meets the high quality standards set by the IOM.4 Addressing the barriers to timely, efficient, and 
equitable care is necessary in order for IO to realize its full potential. The study of new models of care, 
by themselves and in combination, should be a focal point for the field of IO in its next stage of 
evolution.  
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